Skip to main content
. 2021 Aug 28;13(1):81–93. doi: 10.1016/j.jcmgh.2021.08.018

Figure 6.

Figure 6

Intestinal permeability in MR1-deficient and i6-FP-treated mice. (A) FITC-dextran concentration in the plasma 4 hours after the oral administration of FITC-dextran to MR1−/− (n = 16) and littermate WT (n = 15) (A), or WT mice with (n = 15) or without i6-FP treatment (n = 15) (B). Data are represented as the mean ± SEM in each group. Significance was determined using Welch’s t-test. ∗P < .05. Each symbol represents data from an individual mouse.